GlassScriptPhysician profile
Armen Ovsepian
NPI 1629076146
$15,405.42
in general payments reported to CMS, 2019-2025
29 companies · $1,872 in 2025
The $1,872 reported for 2025 was more than what 93% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,910 · 2020: $1,140 · 2021: $2,227 · 2022: $2,797 · 2023: $2,471 · 2024: $1,988 · 2025: $1,872.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,955 · Travel and Lodging: $376.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,955.01 |
| Travel and Lodging | $376.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $4,162.03 | 2019-2025 | Aveir, Ultreon, Jot Dx |
| Medtronic, INC. | $2,343.40 | 2021-2025 | Micra, Selectsecure, Azure Xt Dr Mri Surescan |
| Medtronic Vascular, INC. | $1,690.74 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $1,508.45 | 2019-2025 | |
| Elutia, INC. | $936.00 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $734.18 | 2019-2025 | Camzyos, Eliquis |
| Biosense Webster, INC. | $583.00 | 2019-2025 | Qdot Micro Catheter, Carto 3, Qdot Micro |
| Janssen Pharmaceuticals, INC | $530.11 | 2019-2024 | Xarelto |
| Boston Scientific Corporation | $511.75 | 2019-2025 | Watchman Flx, Farapulse |
| Sanofi-Aventis U.S. LLC | $316.33 | 2019-2024 | |
| Pfizer INC. | $297.10 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $245.61 | 2021-2023 | Verquvo |
| Atricure, INC. | $221.92 | 2019-2024 | |
| Kestra Medical Technology Services, INC. | $194.82 | 2022-2024 | Assure Wcd |
| Inari Medical, INC. | $179.06 | 2021 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $177.75 | 2022-2024 | Inspire |
| Philips North America LLC | $121.54 | 2022-2025 | Ambulatory Monitoring & Diagnostics Undivided, (5091) Amb Mon & Diag Und, (Cm9) Amb Mon & Diag Und |
| Amgen INC. | $119.44 | 2019-2024 | Repatha |
| Astrazeneca Pharmaceuticals LP | $110.26 | 2019-2025 | Wainua |
| Cardiva Medical, INC. | $87.68 | 2021-2025 | Cardiva Vascade 6/7f Vcs, Cardiva Vascade Mvp Vvcs 6-12f |
| Kiniksa Pharmaceuticals, LTD. | $55.20 | 2023 | Arcalyst |
| Daiichi Sankyo INC. | $55.19 | 2023-2024 | Injectafer |
| Esperion Therapeutics, INC. | $53.46 | 2020-2024 | Nexletol |
| Impulse Dynamics (USA) INC. | $35.52 | 2021 | |
| Chiesi USA, INC. | $34.30 | 2024 | Kengreal, Cleviprex |
| Cvrx, INC. | $33.82 | 2024 | Barostim Neo System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $29.41 | 2021 | |
| Kiniksa Pharmaceuticals International, Plc | $19.05 | 2024 | Arcalyst |
| Novo Nordisk INC | $18.30 | 2023 | Ozempic, Rybelsus |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Armen Ovsepian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.